Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.54 |
| ▸ | CTSD | P07339 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11853756 | 0.98 | STAT3 (0.53) | STAT3CTSDNPC1RAB9AHPGD | |
| SCHEMBL1276319 | 0.90 | STAT3 (0.46) | STAT3CTSDNPC1RAB9AHPGD | |
| SCHEMBL28622158 | 0.88 | CTSD (0.56) | STAT3CTSDNPC1RAB9AHPGD | |
| SCHEMBL9134542 | 0.86 | CTSD (0.53) | STAT3CTSDNPC1RAB9AHPGD | |
| SCHEMBL31022703 | 0.86 | CTSD (0.53) | STAT3CTSDNPC1RAB9AHPGD | |
| SCHEMBL3789792 | 0.85 | NPC1 (0.50) | NPC1RAB9AHPGDTP53ALDH1A1 | |
| SCHEMBL10608286 | 0.85 | CTSD (0.51) | STAT3CTSDNPC1RAB9AHPGD | |
| SCHEMBL29482240 | 0.85 | CTSD (0.51) | STAT3CTSDNPC1RAB9AHPGD | |
| SCHEMBL714956 | 0.84 | STAT3 (0.56) | STAT3CTSDNPC1RAB9AHPGD | |
| Thymol SCHEMBL926060 | 0.81 | IDO1 (0.50) | NPC1RAB9AHPGDALDH1A1KCNK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655386-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF CARBON-CONTAINING NON-NITROGEN COMPOUNDS | Fertis India Pvt Ltd (IN) | 2025-12-03 | — | — | EP | claimed |
| WO-2024121870-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF CARBON-CONTAINING NON-NITROGEN COMPOUNDS | FERTIS INDIA PVT. LTD. (IN) | 2024-06-13 | — | — | WO | claimed |
| US-20220170066-A1 | DIFFERENTIATION OF LYME DISEASE AND SOUTHERN TICK-ASSOCIATED RASH ILLNESS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2022-06-02 | — | — | US | claimed |
| US-20190016745-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2019-01-17 | — | — | US | claimed |
| EP-3400231-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS | Technion Research & Development Foundation Limited (IL) | 2018-11-14 | — | — | EP | claimed |
| US-20180282361-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | ELOXX PHARMACEUTICALS LTD. (IL) | 2018-10-04 | — | — | US | claimed |
| EP-3344641-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | Eloxx Pharmaceuticals Ltd. (IL) | 2018-07-11 | — | — | EP | claimed |
| EP-2921162-B1 | OIL-IN-WATER EMULSION COMPOSITION | KAO CORP (JP) | 2017-08-02 | — | — | EP | claimed |
| WO-2017118967-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2017-07-13 | — | — | WO | claimed |
| WO-2017037719-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | ELOXX PHARMACEUTICALS LTD. (IL) | 2017-03-09 | — | — | WO | claimed |
| WO-2012173458-A9 | STABILIZED ACTIVE MATERIALS CONTAINED IN PLANT CELLS AND METHOD FOR PREPARING SAME | (주)아모레퍼시픽 (KR) | 2013-03-07 | — | — | WO | claimed |
| WO-2012173458-A2 | STABILIZED ACTIVE MATERIALS CONTAINED IN PLANT CELLS AND METHOD FOR PREPARING SAME | (주)아모레퍼시픽 (KR) | 2012-12-20 | — | — | WO | claimed |
| EP-1121937-A1 | VACCINE PREPARATIONS CONTAINING SAPONINS | THE KITASATO INSTITUTE (JP) | 2001-08-08 | — | — | EP | claimed |
| EP-0174064-B1 | COMPOSITIONS AND COMPOUNDS FOR THE TREATMENT OF PROSTATIC ADENOMA | INVERNI DELLA BEFFA S.P.A. (IT) | 1989-12-06 | — | — | EP | claimed |
| EP-4714430-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-4706634-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-11 | — | — | EP | disclosed |
| EP-4706633-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-3984393-A | BACTERICIDES | THE UPJOHN COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
| US-3976667-A | ANTIBIOTIC | THE UPJOHN COMPANY (US) | 1976-08-24 | — | — | US | disclosed |
| US-3944562-A | ANTIBIOTIC | THE UPJOHN COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190016745-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS | ALPI, MGAM, AASDHPPT | STAT3 1481/4885CTSD 2110/4885NPC1 1164/4885 |
| US-20180282361-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | UPF1, AARS1, NUDT21 | STAT3 3057/4885CTSD 4036/4885NPC1 631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.